Standard BioTools Signs New Agreement for Mass Cytometry Business Sale
Standard BioTools has entered into a new purchase agreement with Element Biosystems, a subsidiary of GMT Venture, for its Mass Cytometry business. This comes after Standard BioTools determined that GMT Venture's unsolicited acquisition proposal was superior to previous offers.
Story updates
08:48:39 PM UTC
SquawkNews
Standard BioTools will sell its Mass Cytometry business to GMT Venture’s Element for about $5.5M cash and terminated its prior deal. The new terms are expected to increase net cash for the Treeline merger by about $15M versus the prior transaction, subject to approvals and closing.Material DetailsC…